• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

握力弱预示心力衰竭患者有更高的非计划性医疗保健利用。

Weak grip strength predicts higher unplanned healthcare utilization among patients with heart failure.

机构信息

Lien Centre for Palliative Care, Duke-NUS Medical School, 8 College Rd, Singapore, 169857.

Program in Health Services and Systems Research, Duke-NUS Medical School, Singapore.

出版信息

ESC Heart Fail. 2024 Feb;11(1):306-314. doi: 10.1002/ehf2.14573. Epub 2023 Nov 21.

DOI:10.1002/ehf2.14573
PMID:37990632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10804178/
Abstract

AIMS

Frailty increases healthcare utilization and costs for patients with heart failure but is challenging to assess in clinical settings. Hand grip strength (GS) is a single-item measure of frailty yet lacks evidence as a potential screening tool to identify patients at risk of higher unplanned events and related healthcare costs. We examined the association of baseline and longitudinal GS measurements with healthcare utilization and costs among patients with advanced heart failure.

METHODS AND RESULTS

Between July 2017 and April 2019, we enrolled 251 patients with symptoms of advanced heart failure (New York Heart Association class III or IV) in a prospective cohort study in Singapore. We measured GS at baseline and every 4 months for 2 years and linked patients' survey data with their medical and billing records. We categorized patients as having weak GS if their GS measurement was below the 5th percentile of the age- and gender-specific normative GS values in Singapore. We assessed the association between baseline GS and healthcare utilization (unplanned and planned events and healthcare costs, total costs, and length of inpatient stay) over the next 2 years using regression models. We investigated the association between longitudinal 4-monthly GS assessments and the ensuing 4 months of healthcare utilization and costs using mixed-effects logistic and two-part regression models. At baseline, 22.5% of patients had weak GS. Baseline and longitudinal GS measurements were significantly associated with longer length of inpatient stay, greater likelihood of unplanned events, and higher related costs. Patients with weak GS had higher odds of an unplanned event occurring by 8 percentage points [95% confidence interval (CI) (0.01, 0.14), P = 0.026], incurred longer inpatient stays by 4 days [95% CI (1.97, 6.79), P = 0.003], and additional SG$ 4792 [US$ ~ 3594, 95% CI (1894, 7689), P = 0.014] in unplanned healthcare costs over the next 4 months.

CONCLUSIONS

GS is a simple tool to identify and monitor heart failure patients at risk of unplanned events, longer inpatient stays, and higher related healthcare costs. Findings support its routine use in clinical settings.

摘要

目的

衰弱会增加心力衰竭患者的医疗保健利用和成本,但在临床环境中评估衰弱具有挑战性。握力(GS)是一种衡量衰弱的单项指标,但缺乏作为潜在筛查工具的证据,无法识别有更高非计划性事件和相关医疗保健费用风险的患者。我们研究了基线和纵向 GS 测量值与晚期心力衰竭患者的医疗保健利用和成本之间的关系。

方法和结果

2017 年 7 月至 2019 年 4 月,我们在新加坡的一项前瞻性队列研究中招募了 251 名有晚期心力衰竭症状的患者(纽约心脏协会 [NYHA] 心功能 III 或 IV 级)。我们在基线和每 4 个月测量一次 GS,为期 2 年,并将患者的调查数据与他们的医疗和计费记录相关联。如果 GS 测量值低于新加坡年龄和性别特定的 GS 值的第 5 百分位数,则将患者归类为握力较弱。我们使用回归模型评估基线 GS 与未来 2 年内的医疗保健利用(非计划性和计划性事件以及医疗保健费用、总费用和住院时间)之间的关系。我们使用混合效应逻辑和两部分回归模型研究了每 4 个月的纵向 GS 评估与随后的 4 个月医疗保健利用和成本之间的关系。基线时,22.5%的患者握力较弱。基线和纵向 GS 测量值与较长的住院时间、更高的非计划性事件发生率和更高的相关成本显著相关。握力较弱的患者发生非计划性事件的可能性高 8 个百分点 [95%置信区间(CI)(0.01,0.14),P=0.026],住院时间延长 4 天 [95%CI(1.97,6.79),P=0.003],并且在接下来的 4 个月内非计划性医疗保健费用增加 SG$4792 [US$~3594,95%CI(1894,7689),P=0.014]。

结论

GS 是一种简单的工具,可以识别和监测有非计划性事件、住院时间延长和更高相关医疗保健费用风险的心力衰竭患者。研究结果支持其在临床环境中的常规使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d22/10804178/8f2777622b7a/EHF2-11-306-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d22/10804178/4390d4e14a6e/EHF2-11-306-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d22/10804178/8f2777622b7a/EHF2-11-306-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d22/10804178/4390d4e14a6e/EHF2-11-306-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d22/10804178/8f2777622b7a/EHF2-11-306-g002.jpg

相似文献

1
Weak grip strength predicts higher unplanned healthcare utilization among patients with heart failure.握力弱预示心力衰竭患者有更高的非计划性医疗保健利用。
ESC Heart Fail. 2024 Feb;11(1):306-314. doi: 10.1002/ehf2.14573. Epub 2023 Nov 21.
2
Hand Grip Strength Predicts Mortality and Quality of Life in Heart Failure: Insights From the Singapore Cohort of Patients With Advanced Heart Failure.握力强度可预测心力衰竭患者的死亡率和生活质量:来自新加坡晚期心力衰竭患者队列的研究结果。
J Card Fail. 2023 Jun;29(6):911-918. doi: 10.1016/j.cardfail.2022.11.009. Epub 2022 Dec 13.
3
Multifactorial risk factors for hospital readmissions among patients with symptoms of advanced heart failure.患有晚期心力衰竭症状的患者再次住院的多因素危险因素。
ESC Heart Fail. 2024 Apr;11(2):1144-1152. doi: 10.1002/ehf2.14670. Epub 2024 Jan 25.
4
Frailty Phenotype and Healthcare Costs and Utilization in Older Men.老年人虚弱表型与医疗保健费用和利用
J Am Geriatr Soc. 2020 Sep;68(9):2034-2042. doi: 10.1111/jgs.16522. Epub 2020 May 13.
5
Grip strength measurement for frailty assessment in patients with vascular disease and associations with comorbidity, cardiac risk, and sarcopenia.握力测量用于评估血管疾病患者的虚弱程度,以及与合并症、心脏风险和肌肉减少症的关系。
J Vasc Surg. 2018 May;67(5):1512-1520. doi: 10.1016/j.jvs.2017.08.078. Epub 2017 Dec 21.
6
Outpatient grip strength measurement predicts survival, perioperative adverse events, and nonhome discharge among patients with vascular disease.门诊握力测量可预测血管疾病患者的生存、围手术期不良事件和非家庭出院。
J Vasc Surg. 2021 Jan;73(1):250-257. doi: 10.1016/j.jvs.2020.03.060. Epub 2020 May 1.
7
The impact of a community-based heart failure multidisciplinary team clinic on healthcare utilization and costs.社区心力衰竭多学科团队诊所对医疗保健利用和成本的影响。
ESC Heart Fail. 2022 Feb;9(1):676-684. doi: 10.1002/ehf2.13689. Epub 2021 Nov 7.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Frailty Assessment in Advanced Heart Failure.晚期心力衰竭的衰弱评估
J Card Fail. 2016 Oct;22(10):840-4. doi: 10.1016/j.cardfail.2016.02.003. Epub 2016 Feb 13.
10
Modified-frailty index does not independently predict complications, hospital length of stay or 30-day readmission rates following posterior lumbar decompression and fusion for spondylolisthesis.改良衰弱指数不能独立预测腰椎滑脱后路减压融合术后并发症、住院时间或 30 天再入院率。
Spine J. 2021 Nov;21(11):1812-1821. doi: 10.1016/j.spinee.2021.05.011. Epub 2021 May 16.

引用本文的文献

1
Low Muscle Strength Assessed with Dynamometry in Elderly Polypathological Patients with Acute Heart Failure: PROFUND-IC Registry.采用握力计评估老年多病理急性心力衰竭患者的肌肉力量:PROFUND-IC注册研究
J Clin Med. 2024 Aug 18;13(16):4873. doi: 10.3390/jcm13164873.

本文引用的文献

1
Sex differences in the impact of physical frailty on outcomes in heart failure.身体虚弱对心力衰竭结局影响的性别差异。
Heart Lung. 2023 Sep-Oct;61:66-71. doi: 10.1016/j.hrtlng.2023.04.014. Epub 2023 May 6.
2
Quantifying the Eyeball Test: Grip Strength at the Nexus of Frailty, Cachexia and Sarcopenia in Heart Failure.量化眼球测试:心力衰竭中衰弱、恶病质和肌肉减少症关联处的握力
J Card Fail. 2023 Jun;29(6):919-921. doi: 10.1016/j.cardfail.2023.03.002. Epub 2023 Mar 11.
3
Hand Grip Strength Predicts Mortality and Quality of Life in Heart Failure: Insights From the Singapore Cohort of Patients With Advanced Heart Failure.
握力强度可预测心力衰竭患者的死亡率和生活质量:来自新加坡晚期心力衰竭患者队列的研究结果。
J Card Fail. 2023 Jun;29(6):911-918. doi: 10.1016/j.cardfail.2022.11.009. Epub 2022 Dec 13.
4
Healthcare cost expenditures associated to frailty and sarcopenia.与衰弱和肌少症相关的医疗保健费用支出。
BMC Geriatr. 2022 Sep 13;22(1):747. doi: 10.1186/s12877-022-03439-z.
5
Characterizing Sex Differences in Physical Frailty Phenotypes in Heart Failure.心力衰竭患者身体虚弱表型的性别差异特征分析
Circ Heart Fail. 2021 Sep;14(9):e008076. doi: 10.1161/CIRCHEARTFAILURE.120.008076. Epub 2021 Aug 25.
6
Gender differences in the impact of frailty on 90-day hospital readmission in heart failure patients: a retrospective cohort study.衰弱对心力衰竭患者90天再入院影响的性别差异:一项回顾性队列研究。
Eur J Cardiovasc Nurs. 2021 Jun 29;20(5):485–492. doi: 10.1093/eurjcn/zvaa028. Epub 2021 Jan 6.
7
Hospital frailty risk score and adverse health outcomes: evidence from longitudinal record linkage cardiac data.医院脆弱性风险评分与不良健康结局:来自纵向记录链接心脏数据的证据。
Age Ageing. 2021 Sep 11;50(5):1778-1784. doi: 10.1093/ageing/afab073.
8
Gender differences in the prevalence of frailty in heart failure: A systematic review and meta-analysis.性别差异与心力衰竭衰弱患病率的关系:系统评价和荟萃分析。
Int J Cardiol. 2021 Jun 15;333:133-140. doi: 10.1016/j.ijcard.2021.02.062. Epub 2021 Feb 28.
9
Frailty and the risk of all-cause mortality and hospitalization in chronic heart failure: a meta-analysis.衰弱与慢性心力衰竭患者全因死亡率及住院风险:一项荟萃分析
ESC Heart Fail. 2020 Dec;7(6):3427-3437. doi: 10.1002/ehf2.12827. Epub 2020 Sep 21.
10
Epidemiology of heart failure.心力衰竭的流行病学。
Eur J Heart Fail. 2020 Aug;22(8):1342-1356. doi: 10.1002/ejhf.1858. Epub 2020 Jun 1.